Methylprednisolone Completed Phase 3 Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00053976Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease